Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05625802 · ClinicalTrials.gov registry record · Phase 2
Erector Spinae Plane Block for Uncomplicated Renal Colic
A Phase 2 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT05625802: Completed Phase 2 study, sponsored by University of Michigan.
NCT05625802 is a Phase 2 study that has completed, run by University of Michigan. The registered enrollment target is 5 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05625802, a Phase 2 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
This research study is to determine how well the Erector Spinae Plane Block (ESPB) works for kidney stone pain and any possible side effects.
Primary Outcome
Results reflect the number of participants who received a second parenteral pain medication after receiving one already. Data for this outcome was collected via electronic health record query.
Interventions
- DRUG Ropivacaine
- PROCEDURE Erector Spinae Plane Block (ESPB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2023-02-08 |
| Est. Completion | 2024-02-02 |
| Phase | Phase 2 |
What the finished NCT05625802 record still lists
NCT05625802 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Ropivacaine is the first listed.
NCT05625802 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05625802 about?
NCT05625802 is a clinical study titled "Erector Spinae Plane Block for Uncomplicated Renal Colic". This research study is to determine how well the Erector Spinae Plane Block (ESPB) works for kidney stone pain and any possible side effects.
What is the current status of trial NCT05625802?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2023-02-08. Estimated completion is 2024-02-02.
What interventions are being tested in trial NCT05625802?
The interventions under investigation include: Ropivacaine (DRUG), Erector Spinae Plane Block (ESPB) (PROCEDURE).
Who is sponsoring clinical trial NCT05625802?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05625802's enrollment target sits among peer trials
5 2000th of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI